Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review

Posted on by

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 14 May 2022]

 

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
Authors: Jingjing Lv, Hui Wu, Junjie Xu and Jiaye Liu
Content type: Scoping Review 13 May 2022